FAQ/Help |
Calendar |
Search |
Today's Posts |
08-03-2017, 01:27 PM | #1 | ||
|
|||
Member
|
|
||
Reply With Quote |
08-04-2017, 07:20 AM | #2 | ||
|
|||
Member
|
Research paper:
D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats, Lindenbach et al., Br J Pharmacol July 1 2017. D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats - Lindenbach - 2 17 - British Journal of Pharmacology - Wiley Online Library |
||
Reply With Quote |
"Thanks for this!" says: | eds195 (08-04-2017) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
New drug may treat and limit progression of Parkinson's disease ... - Science Daily | Parkinson's News | |||
New Drug May Slow Progression of Parkinson's Disease - Newsmax | Parkinson's News | |||
Free Water Levels Provide a New Biomarker for Parkinson's Disease Progression - Parki | Parkinson's News | |||
Team finds that drug used for another disease slows progression of Parkinson's | Parkinson's Disease | |||
New Parkinson's Drug Could Slow Disease Progression | Parkinson's Disease |